Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays

Basit Öğe Kaydı
dc.contributor.authorYildirim, Ozgen Ahmet
dc.contributor.authorPoyraz, Kerem
dc.contributor.authorErdur, Erkan
dc.date.accessioned2024-04-24T16:02:19Z
dc.date.available2024-04-24T16:02:19Z
dc.date.issued2021
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose Pandemics can be associated with anxiety and depression in cancer patients who are undergoing treatment. In the present study, we aimed to perform a comparative evaluation of the conditions of cancer patients before and during the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) pandemic using the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) to detect the impact of the pandemic on treatment delays that are associated with anxiety and depression in cancer patients. In addition, the effect of public transport use on treatment delays was examined. Methods BDI and BAI were administered to 595 breast, ovarian, colon and gastric cancer patients before and during the pandemic. The questionnaires were administered by the physician blindly, who was unaware of the delay of the patients. The number of days by which the patients delayed their treatment due to the fear of contamination were recorded retrospectively. Correlation analyses were performed between the obtained scores and treatment delays. Results The depression and anxiety levels in cancer patients were found to increase during the pandemic (p = 0.000), and this increase was positively correlated with the disruption of their treatment (p = 0.000, r = 0.81). Depression and anxiety levels and treatment delays were higher in elderly patients (p = 0.021). Depression and anxiety were more pronounced in female patients (p = 0.000). Moreover, treatment delays were more common in patients who had to use public transportation (p = 0.038). Conclusion SARS-CoV-2 pandemic may increase anxiety and depression in cancer patients. This can cause patients to experience treatment delays due to concerns about becoming infected. At this point, if necessary, assistance should be obtained from psychiatric and public health experts.en_US
dc.identifier.doi10.1007/s11136-021-02795-4
dc.identifier.endpage1912en_US
dc.identifier.issn0962-9343
dc.identifier.issn1573-2649
dc.identifier.issue7en_US
dc.identifier.pmid33635508
dc.identifier.startpage1903en_US
dc.identifier.urihttps://doi.org/10.1007/s11136-021-02795-4
dc.identifier.urihttps://hdl.handle.net/11468/14743
dc.identifier.volume30en_US
dc.identifier.wosWOS:000622252900001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofQuality of Life Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDepressionen_US
dc.subjectAnxietyen_US
dc.subjectCancer Patientsen_US
dc.subjectSars-Cov-2en_US
dc.titleDepression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delaysen_US
dc.titleDepression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu